(Q52936396)
Statements
CD52 is not a promising immunotherapy target for most patients with multiple myeloma. (English)
Jörg Westermann
Georg Maschmeyer
Antje van Lessen
Bernd Dörken
Antonio Pezzutto
1 October 2005
82
3
248-250
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference